|

货币单位:美元(USD)

艾尔建制药公司

Allergan Ltd. (Ireland) (agn)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

Robert A. Michael	Robert A. Michael is currently the Chief Executive Officer & Director at AbbVie, Inc. He is also the Chief Executive Officer at Fremont Holding LLC, Tobira Therapeutics, Inc., and President & Vice Chairman at Allergan Ltd. (Ireland). Additionally, he holds the positions of President & Director at Allergan GI Corp., Director at AbbVie Biotherapeutics Ltd., and President & Chief Operating Officer at AbbVie Ltd. (United Kingdom). Previously, he worked at Abbott Laboratories as the Division Controller-Nutrition Supply Chain from 1993 to 2012. Mr. Michael completed his undergraduate degree at Kelley School of Business and earned an MBA from UCLA Anderson School of Management.

Robert A. Michael

Robert A. Michael is currently the Chief Executive Officer & Director at AbbVie, Inc. He is also the Chief Executive Officer at Fremont Holding LLC, Tobira Therapeutics, Inc., and President & Vice Chairman at Allergan Ltd. (Ireland). Additionally, he holds the positions of President & Director at Allergan GI Corp., Director at AbbVie Biotherapeutics Ltd., and President & Chief Operating Officer at AbbVie Ltd. (United Kingdom). Previously, he worked at Abbott Laboratories as the Division Controller-Nutrition Supply Chain from 1993 to 2012. Mr. Michael completed his undergraduate degree at Kelley School of Business and earned an MBA from UCLA Anderson School of Management.